469 related articles for article (PubMed ID: 15986481)
21. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
22. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
23. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
24. Reirradiation of locally recurrent nasopharyngeal carcinoma.
Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
26. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
28. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
29. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.
Park JH; Nam SY; Lee SW; Kim SB; Kim SY; Lee BJ; Cho KJ; Kim JH; Ahn SD; Shin SS; Choi SH; Ahn JH; Choi EK
Auris Nasus Larynx; 2005 Mar; 32(1):43-8. PubMed ID: 15882825
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
[TBL] [Abstract][Full Text] [Related]
32. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.
Lin JC; Jan JS; Hsu CY; Jiang RS; Wang WY
Br J Cancer; 2003 Jan; 88(2):187-94. PubMed ID: 12610501
[TBL] [Abstract][Full Text] [Related]
33. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
[TBL] [Abstract][Full Text] [Related]
35. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
36. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy.
Varan A; Ozyar E; Corapçioğlu F; Köksal Y; Aydin B; Yazici N; Akyüz C; Büyükpamukçu M
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1116-20. PubMed ID: 18786778
[TBL] [Abstract][Full Text] [Related]
37. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
38. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns.
Leung TW; Tung SY; Sze WK; Wong FC; Yuen KK; Lui CM; Lo SH; Ng TY; O SK
Head Neck; 2005 Jul; 27(7):555-65. PubMed ID: 15880410
[TBL] [Abstract][Full Text] [Related]
39. [The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis].
Mücke R; Ziegler PG; Libera T; Klautke G; Fietkau R
Strahlenther Onkol; 2000 Aug; 176(8):350-5. PubMed ID: 10987017
[TBL] [Abstract][Full Text] [Related]
40. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
